ASX - Delayed Quote AUD

4DMedical Limited (4DX.AX)

0.2800
0.0000
(0.00%)
At close: May 16 at 4:10:20 PM GMT+10
Loading Chart for 4DX.AX
  • Previous Close 0.2800
  • Open 0.2800
  • Bid 0.2800 x --
  • Ask 0.2850 x --
  • Day's Range 0.2750 - 0.2850
  • 52 Week Range 0.2250 - 0.7150
  • Volume 518,310
  • Avg. Volume 1,006,066
  • Market Cap (intraday) 126.154M
  • Beta (5Y Monthly) 1.40
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1100
  • Earnings Date Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.70

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.

4dmedical.com

145

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 4DX.AX

View More

Performance Overview: 4DX.AX

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

4DX.AX
41.67%
S&P/ASX 200 [XJO] (^AXJO)
2.26%

1-Year Return

4DX.AX
55.20%
S&P/ASX 200 [XJO] (^AXJO)
5.87%

3-Year Return

4DX.AX
61.38%
S&P/ASX 200 [XJO] (^AXJO)
17.63%

5-Year Return

4DX.AX
80.95%
S&P/ASX 200 [XJO] (^AXJO)
54.38%

Compare To: 4DX.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4DX.AX

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    126.15M

  • Enterprise Value

    115.02M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    18.91

  • Price/Book (mrq)

    2.11

  • Enterprise Value/Revenue

    22.32

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.32%

  • Return on Equity (ttm)

    -52.37%

  • Revenue (ttm)

    5.86M

  • Net Income Avi to Common (ttm)

    -39.54M

  • Diluted EPS (ttm)

    -0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.95M

  • Total Debt/Equity (mrq)

    8.05%

  • Levered Free Cash Flow (ttm)

    -28.41M

Research Analysis: 4DX.AX

View More

People Also Watch